Stock screener

HRTX

Conviction 0HealthcareScan · Thu, Jun 25, 2026
HRTX$0.4114-5.05%
ResistanceSupportVol 14
63 bars
Vol MA14 3.88M
Mar 26Apr 14May 1May 19Jun 8Jun 25
HERON THERAPEUTICS, INC. /DE/PHARMACEUTICAL PREPARATIONSwww.herontx.com
Price0.4114
Change-5.05%
Gap+1.11%
Rel volume0.42×
Avg volume4.92M
Avg $ vol2.24M
SMA 200.4876
SMA 500.8174
SMA 2001.09
Price vs 50-49.67%
Price vs 200-62.29%
MA stackbearish
50/200 cross
Supertrenddown · 0.5581
RSI (14)30
MACD hist0.02
MACD crossbull · 3d
Stoch %K / %D29 / 32
ADX (14)44
+DI / −DI15 / 33
RSI divergence
MACD divergenceBullish
ATR %+12.69%
ADR %10.78%
52w high2.23
52w low0.3820
From 52w high-81.55%
Above 52w low+7.70%
New 52w highNo
SqueezeOff
Bollinger width131.06%
%B0.38
Donchian pos5.68%
Donchian high0.8996
Donchian low0.3820
AVWAP (52w high)1.08
vs AVWAP high-62.02%
AVWAP (52w low)0.4150
vs AVWAP low-0.86%
OBV trendDown
Chaikin MF (20)-0.46
Today vs 20d0.42×
Avg vol (14d)3.88M
Avg vol (20d)4.92M
Avg $ vol (20d)2.24M
Market cap77.87M
RS 3m (vs SPY)-55.58%
RS 6m (vs SPY)-74.41%
RS line new highNo
Trend template0/8
Technical rank3.1
1 week+6.22%
1 month-53.42%
3 months-48.34%
6 months-69.30%
1 year-80.87%
YTD-67.35%
P/E-3.86
P/B8.52
P/S0.50
P/FCF-2.79
EPS-0.1200
Div yield
ROE-221.02%
ROA-8.20%
Debt/Eq
Current2.53
EV/EBITDA-231.04
Gross margin73.31%
Net margin-13.04%
Rev growth7.36%
EPS growth-48.71%
Price target
Target upside
Analyst rating
Institutional
Ent. value51.75M
Revenue34.71M
Net income-8.11M
Gross profit24.07M
Free cash flow-27.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out189.28M
Employees128
ListedThu, Aug 27, 1987
Free float136.31M
Float %72.3%
Short interest40.16M
Days to cover23.7d
Short volume74.1%
Squeeze score85 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank3.1 / 100
Group rank
Status laneNo active setup
Setup direction
Pattern family
Resistance1.32
Support0.3860
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HRTX

All disclosures →
No recent disclosed trades by Congress in HRTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HRTX · 6 buys · 4 sells

InsiderSideShares
Forbes William P
EVP, Chief Development Officer · Common Stock · 2026-06-06
Exercise12.5K
Forbes William P
EVP, Chief Development Officer · Restricted Stock Units · 2026-06-06
Exercise12.5K
Hensley Mark Earl
Chief Operating Officer · Common Stock · 2026-05-06
Exercise125K
Hensley Mark Earl
Chief Operating Officer · Restricted Stock Units · 2026-05-06
Exercise125K
Hensley Mark Earl
Chief Operating Officer · Restricted Stock Units · 2026-04-30
Exercise11.77K
Collard Craig A
Chief Executive Officer · Common Stock · 2026-04-30
Exercise34.79K
Duarte Ira
EVP, Chief Financial Officer · Restricted Stock Units · 2026-04-30
Exercise11.69K
Forbes William P
EVP, Chief Development Officer · Common Stock · 2026-04-30
Exercise11.77K
Hensley Mark Earl
Chief Operating Officer · Common Stock · 2026-04-30
Exercise11.77K
Duarte Ira
EVP, Chief Financial Officer · Common Stock · 2026-04-30
Exercise11.69K

SEC filings

EDGAR filings in HRTX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.